Elevated neutrophil to lymphocyte ratio is associated with decreased amputation-free survival after femoropopliteal percutaneous revascularization

被引:7
|
作者
King, Alexander H. [1 ]
Kwan, Stephen [1 ]
Schmaier, Alvin H. [1 ]
Kumins, Norman H. [1 ]
Harth, Karem C. [1 ]
Colvard, Benjamin D. [1 ]
Wong, Virginia L. [1 ]
Kashyap, Vikram S. [1 ]
Cho, Jae S. [1 ]
机构
[1] Univ Hosp Cleveland, Med Ctr, 11100 Euclid Ave, Cleveland, OH 44106 USA
关键词
Peripheral arterial disease; Neutrophils; Lymphocytes; Vascular surgical procedures; PERIPHERAL ARTERY-DISEASE; VASCULAR-DISEASE; MORTALITY; OUTCOMES; PREVALENCE; ACTIVATION; CELLS; CARE;
D O I
10.23736/S0392-9590.21.04699-X
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: An elevated neutrophil-lymphocyte ratio (NLR) is a biomarker associated with adverse outcomes after cardiovascular surgery. This study evaluates the association of preoperative NLR with clinical outcomes after peripheral vascular intervention (PVI) of the femoropopliteal segments. Methods: A retrospective review identified 488 patients who underwent percutaneous interventions of femoropopliteal arteries between 2011 and 2018 and had a pre-procedural complete blood count with differential with normal white blood cell count within 30 days prior to intervention. Amputation-free survival (AFS), survival, and freedom from major amputation were assessed using Kaplan-Meier methods. Cohorts of patients with NLR <3 (Low), 3-4 (Mid), and >4 (High) were compared using univariate and multivariable statistical models. In these analyses NLR was analyzed as a continuous variable to correlate with clinical outcomes. Results: Mean age was 71.7 +/- 12.8 years and males constituted 55.5%. The majority of patients presented with chronic limb threatening ischemia (CLTI, 78.5%). Increasing NLR was correlated with increasing rates of comorbidities, except for smoking history. The 30-day mortality rates increased with increasing NLR: 1.4%, 4.3%, and 7.0% for low (<3), mid (3-4) and high (>4) NLR groups, respectively (P=0.005). Patients with a lower pre-operative NLR achieved significantly greater amputation-free survival at 4-year follow-up: low NLR, 65.5%; mid NLR, 37.5%; and high NLR, 17.6% (P<0.0001). By multivariable analysis, increasing NLR, advanced age, CLTI, and dialysis-dependent renal failure reduced AFS. Conclusions: Elevated NLR is an independent predictor of decreased AFS following percutaneous interventions of femoropopliteal segments. Further research on identification and modulation of risk factors for high NLR are warranted. (Cite this article as: King AH, Kwan S, Schmaier AH, Kumins NH, Harth KC, Colvard BD, et al. Elevated neutrophil to lymphocyte ratio is associated with decreased amputation-free survival after femoropopliteal per cutaneous revascularization. Int Angiol 2021;40:442-9. DOI: 10.23736/S0392-9590.21.04699-X)
引用
收藏
页码:442 / 449
页数:8
相关论文
共 50 条
  • [1] Neutrophil-Lymphocyte Ratio Predicts Amputation-Free Survival Following Percutaneous Femoropopliteal Intervention
    King, Alexander H.
    Harth, Karem
    Kumins, Norman
    Wong, Virginia L.
    Colvard, Benjamin
    Kashyap, Vikram S.
    Cho, Jae
    JOURNAL OF VASCULAR SURGERY, 2020, 72 (01) : E214 - E215
  • [2] Prognostic Significance of an Elevated Neutrophil-Lymphocyte Ratio in the Amputation-free Survival of Patients with Chronic Critical Limb Ischemia
    Gonzalez-Fajardo, Jose A.
    Brizuela-Sanz, Jose A.
    Aguirre-Gervas, Beatriz
    Merino-Diaz, Borja
    Del Rio-Sola, Lourdes
    Martin-Pedrosa, Miguel
    Vaquero-Puerta, Carlos
    ANNALS OF VASCULAR SURGERY, 2014, 28 (04) : 999 - 1004
  • [3] Elevated serum phosphate levels are associated with decreased amputation-free survival after interventions for critical limb ischemia
    Zettervall, Sara L.
    Soden, Peter A.
    Ultee, Klaas H. J.
    Seldon, Crystal
    Oh, Jinhee
    McGann, Kevin
    Schermerhorn, Marc L.
    Guzman, Raul J.
    JOURNAL OF VASCULAR SURGERY, 2017, 65 (02) : 431 - 437
  • [4] The Neutrophil-to-lymphocyte Ratio is Associated With Amputation Free Survival in Critical Limb Ischemia
    van Rhijn-Brouwer, Femke C.
    Gremmels, Hendrik
    van Koeverden, Ian D.
    Teraa, Martin
    Pasterkamp, Gerard
    de Borst, Gert J.
    Fledderus, Joost O.
    Verhaar, Marianne C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [5] Factors Associated With 1-year Amputation-free Survival Following Lower Extremity Revascularization
    Zarrintan, Sina
    Willie-Permor, Daniel
    Patel, Rohini J.
    Alsaigh, Tom
    Malas, Mahmoud
    JOURNAL OF VASCULAR SURGERY, 2023, 77 (06) : E196 - E197
  • [6] Amputation-Free Survival after Crural Percutaneous Transluminal Angioplasty for Critical Limb Ischemia
    Strom, M.
    Konge, L.
    Lonn, L.
    Schroeder, T. V.
    Rordam, P.
    SCANDINAVIAN JOURNAL OF SURGERY, 2016, 105 (01) : 42 - 48
  • [7] Long-Term Limb Salvage and Amputation-Free Survival After Femoropopliteal Bypass and Femoropopliteal PTA for Critical Ischemia in a Clinical Cohort
    Altreuther, Martin
    Mattsson, Erney
    VASCULAR AND ENDOVASCULAR SURGERY, 2019, 53 (02) : 112 - 117
  • [8] Amputation-free survival, limb symptom alleviation, and reintervention rates after open and endovascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia
    Perlander, Angelica
    Jivegard, Lennart
    Nordanstig, Joakim
    Svensson, Mikael
    Osterberg, Klas
    JOURNAL OF VASCULAR SURGERY, 2020, 72 (06) : 1987 - 1995
  • [9] Neutrophil to Lymphocyte Ratio as a Predictor of Outcomes after Amputation
    Pierre-Louis, Willythssa S.
    Bath, Jonathan
    Mikkilineni, Sesank
    Scott, Michael C.
    Harlander-Locke, Michael
    Rasor, Zachary
    Smeds, Matthew
    ANNALS OF VASCULAR SURGERY, 2019, 54 : 84 - 91
  • [10] Elevated Neutrophil-to-Lymphocyte ratio at Day+100 is Associated With Decreased Progression-Free Survival After Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Ferreira, Gisela
    Roque, Adriana
    Pereira, Marta Isabel
    Cortesao, Emilia
    Espadana, Ana Isabel
    Sarmento-Ribeiro, Ana Bela
    Geraldes, Catarina
    Ribeiro, Leticia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E64 - E65